Product Information
SUMATRIPTAN SUCC 100 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.4341 per EA under NDC 16714079801. Its NADAC has been published 391 times since Jan 2, 2019.
Strength
100 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714079801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA078327On Market Since
6/18/2018
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 100 MG TABLET has been published 391 times since Jan 2, 2019, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4341 per EA |
|---|---|
| All-time high | $0.6215 (Jun 10, 2020) |
| All-time low | $0.3720 (Nov 20, 2024) |
| 52-week high | $0.4721 |
| 52-week low | $0.4322 |
| Median price | $0.5199 |
| Average price | $0.5194 |
| Largest weekly change | -23.3% (Nov 20, 2024) |
| Weeks tracked | 391 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 100 MG TABLET, manufactured by NorthStar Rx LLC, is $0.4341 per EA (NDC 16714079801), effective Jun 24, 2026.
How has the price of SUMATRIPTAN SUCC 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 100 MG TABLET has declined 25.0%. It has been tracked across 391 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 100 MG TABLET?
Since Jan 2, 2019, the NADAC for SUMATRIPTAN SUCC 100 MG TABLET has ranged from a low of $0.3720 (Nov 20, 2024) to a high of $0.6215 (Jun 10, 2020), with a median of $0.5199 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 100 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SUMATRIPTAN SUCC 100 MG TABLET, but none are currently priced below it.
Who manufactures SUMATRIPTAN SUCC 100 MG TABLET?
SUMATRIPTAN SUCC 100 MG TABLET (NDC 16714079801) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification